The treatment of ulcerative colitis with balsalazide sodium
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
http://link.springer.com/content/pdf/10.1007/BF02660619.pdf
Reference16 articles.
1. Azad Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977;2:892–5.
2. Klotz U, Maier K, Fischer C, Heinkel K. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn’s disease. N Eng J Med. 1980;303:1499–502.
3. Dissanayake AS, Truelove SC. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine. Gut. 1973; 14:923–6.
4. Das KM, Eastwood MA, McManus JPA, Sircus W. The metabolism of salicylazosulphapyridine in ulcerative colitis. 1. The relationship between metabolites and the response to treatment in inpatients. Gut. 1973; 14:631–41.
5. Chan RP, Pope DJ, Gilbert AP, Sacra PJ, Baron JH, Lennard-Jones JE. Studies of two novel sulphasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci. 1983;28:609–15.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Gut Microbiota-driven Drug Metabolism in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2020-07-11
2. Drug delivery strategies in the therapy of inflammatory bowel disease;Advanced Drug Delivery Reviews;2014-05
3. A Stability-Indicating LC Method for Analysis of Balsalazide Disodium in the Bulk Drug and in Pharmaceutical Dosage Forms;Chromatographia;2009-03-04
4. A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis;Alimentary Pharmacology & Therapeutics;2002-01-07
5. A double-blind comparison of balsalazide, 6.75 g daily, and sulfasalazine, 3 g daily, in patients with newly diagnosed or relapsed active ulcerative colitis;Alimentary Pharmacology & Therapeutics;2002-01-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3